Biogen Total Assets

Biogen (BIIB) currently reports a total assets of $32B as of June 2026. That compares with $28B in the prior-year period — up 13.3% year over year. Use the charts on this page to explore Biogen's total assets history and peer comparisons.

Biogen's total assets increased from $28B to $32B — a 13.3% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Biogen reported $32B in total assets as of June 2026. That compares with $28B in the prior-year period — up 13.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total assets of $32B, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Biogen, and consider following BIIB for alerts when major investors trade the stock.

Biogen is classified in the Healthcare sector. On total assets, it currently shows $32B. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing BIIB with unrelated industries.